89bio completed target enrollment in histology cohort to evaluate bio89-100 for the treatment of nash

- study designed to build upon positive phase 1b/2a data and provide an early opportunity to demonstrate bio89-100's potential benefits on histology endpoints - - study designed to build upon positive phase 1b/2a data and provide an early opportunity to demonstrate bio89-100's potential benefits on histology endpoints -
ETNB Ratings Summary
ETNB Quant Ranking